Glycosmedia - an international diabetes news service from the UK
  
 
Archived News
October 6th 2008
 
 
  The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance
  Small increments in FPG, within the "normal" range, are associated with a marked decline in glucose-stimulated insulin secretion and the decrease in insulin secretion with increasing FPG is greater in subjects with NGT than IGT and primarily is due to a decline in early-phase insulin secretion (PubMed)
   
  Fasting insulin is a stronger cardiovascular risk factor in women than in men
  In parallel with diabetes, fasting hyperinsulinaemia reflecting insulin resistance in non-diabetic subjects is associated with an increased risk for cardiovascular disease, which is more pronounced in women than in men (PubMed)
   
  Diabetes UK backs National Diabetes Audit in Wales
  Diabetes UK Cymru is encouraging GPs' surgeries to follow the example of paediatric centres in Wales and take part in the National Diabetes Audit (Diabetes UK)
   
  Diabetes Forecast Takes a Look Back and a Step Forward
  For 60 years, Diabetes Forecast, the consumer magazine of the American Diabetes Association (ADA), has been bringing crucial information to people with diabetes. The October issue celebrates the magazine's 60th anniversary with a major redesign that takes on a more contemporary look and includes new features on research, nutrition, and treatment (Market Watch)
   
  F as in Fat
  How obesity policies are failing in America. 144-page PDF (The Trust for America's Health)
   
  Improving treatment for those with both diabetes and mental health
  With those who have a mental illness more likely to have type-2 diabetes, health workers across SA are meeting to discuss improving treatment and prevention (Department of Health, Australia)
   
  Pattern of 24-hour ambulatory blood pressure monitoring in type 2 diabetic patients with cardiovascular dysautonomy
  Type 2 diabetic patients with more severe CAN have higher SBP and PP, especially during the nighttime and early morning, as well as a higher prevalence of nondipping status (PubMed)
   
  Exenatide once weekly versus twice daily for the treatment of type 2 diabetes
  A randomised, open-label, non-inferiority study (The Lancet, UK)
   
  Dr Reddy’s diabetes drug may be delayed
  Rheoscience A/S, the Danish firm conducting phase III clinical trials on Balaglitazone, has run into a financial crisis (Live Mint. Wall Street Journal, USA)
   
  Is diabetes education truly profitable?
  Yes, but educators must explore other money-making opportunities - Yes, but educators must think like a business, act like a business (Endocrine Today, USA)
   
 
  
© Copyright 2008 Glycosmedia Partnership